Söndag 27 April | 05:19:00 Europe / Stockholm

Bifogade filer

Prenumeration

Kalender

Est. tid*
2024-03-26 - Bokslutskommuniké 2023
2023-12-22 - Extra Bolagsstämma 2023
2023-11-23 - Kvartalsrapport 2023-Q3
2023-08-11 - Kvartalsrapport 2023-Q2
2023-05-17 - X-dag ordinarie utdelning COALA 0.00 SEK
2023-05-16 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-03-31 - Bokslutskommuniké 2022
2023-01-26 - Extra Bolagsstämma 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-08-17 - Kvartalsrapport 2022-Q2
2022-05-31 - X-dag ordinarie utdelning COALA 0.00 SEK
2022-05-30 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-05-04 - Kvartalsrapport 2022-Q1
2022-02-23 - Bokslutskommuniké 2021
2021-12-14 - X-dag ordinarie utdelning COALA 0.00 SEK
2021-11-04 - Split COALA 50:1
2021-10-29 - Extra Bolagsstämma 2021
2021-08-10 - Extra Bolagsstämma 2021
2021-06-24 - Kvartalsrapport 2021-Q3
2021-03-25 - Kvartalsrapport 2021-Q2
2020-12-23 - X-dag ordinarie utdelning COALA 0.00 SEK
2020-12-22 - Årsstämma
2020-12-22 - Kvartalsrapport 2021-Q1
2020-10-22 - Bokslutskommuniké 2020
2020-06-25 - Kvartalsrapport 2020-Q3
2020-03-26 - Kvartalsrapport 2020-Q2
2019-12-20 - X-dag ordinarie utdelning COALA 0.00 SEK
2019-12-19 - Årsstämma
2019-12-12 - Kvartalsrapport 2020-Q1
2019-10-30 - Extra Bolagsstämma 2019
2019-10-10 - Bokslutskommuniké 2019
2019-06-26 - Kvartalsrapport 2019-Q3
2019-03-26 - Kvartalsrapport 2019-Q2
2018-12-21 - X-dag ordinarie utdelning COALA 0.00 SEK
2018-12-20 - Årsstämma
2018-12-20 - Kvartalsrapport 2019-Q1
2018-10-11 - Bokslutskommuniké 2018
2018-03-27 - Kvartalsrapport 2018-Q2
2017-12-22 - X-dag ordinarie utdelning COALA 0.30 SEK
2017-12-21 - Årsstämma
2017-10-12 - Bokslutskommuniké 2017
2017-07-21 - Kvartalsrapport 2018-Q1
2017-06-21 - Kvartalsrapport 2017-Q3
2017-03-27 - Kvartalsrapport 2017-Q2
2016-12-22 - X-dag ordinarie utdelning COALA 0.25 SEK
2016-12-21 - Årsstämma
2016-12-21 - Kvartalsrapport 2017-Q1
2016-10-19 - Bokslutskommuniké 2016
2016-06-23 - Kvartalsrapport 2016-Q3
2016-03-24 - Kvartalsrapport 2016-Q2
2015-12-18 - X-dag ordinarie utdelning COALA 0.25 SEK
2015-12-17 - Årsstämma
2015-12-17 - Kvartalsrapport 2016-Q1
2015-10-22 - Bokslutskommuniké 2015
2015-06-23 - Kvartalsrapport 2015-Q3
2015-03-26 - Kvartalsrapport 2015-Q2
2014-12-19 - X-dag ordinarie utdelning COALA 0.00 SEK
2014-12-18 - Årsstämma
2014-12-18 - Kvartalsrapport 2015-Q1
2014-10-23 - Bokslutskommuniké 2014
2014-06-26 - Kvartalsrapport 2014-Q3
2014-04-02 - Kvartalsrapport 2014-Q2
2014-01-17 - X-dag ordinarie utdelning COALA 0.00 SEK
2014-01-16 - Årsstämma
2014-01-15 - Kvartalsrapport 2014-Q1
2013-10-31 - Analytiker möte 2013
2013-10-31 - Bokslutskommuniké 2013
2013-06-27 - Kvartalsrapport 2013-Q3
2013-06-05 - Split COALA 200:1
2013-03-27 - Extra Bolagsstämma 2013
2013-03-25 - Kvartalsrapport 2013-Q2
2013-01-18 - X-dag ordinarie utdelning COALA 0.00 SEK
2013-01-17 - Årsstämma
2013-01-16 - Kvartalsrapport 2013-Q1
2012-10-24 - Bokslutskommuniké 2012
2012-06-27 - Kvartalsrapport 2012-Q3
2012-03-30 - Kvartalsrapport 2012-Q2
2012-01-20 - X-dag ordinarie utdelning COALA 0.00 SEK
2012-01-19 - Årsstämma
2012-01-18 - Kvartalsrapport 2012-Q1
2011-10-27 - Bokslutskommuniké 2011
2011-06-30 - Kvartalsrapport 2011-Q3
2011-04-06 - Kvartalsrapport 2011-Q2
2011-01-21 - X-dag ordinarie utdelning COALA 0.00 SEK
2011-01-20 - Årsstämma
2011-01-19 - Kvartalsrapport 2011-Q1
2010-10-22 - Kvartalsrapport 2010-Q3
2010-10-21 - Bokslutskommuniké 2010
2010-06-23 - Kvartalsrapport 2010-Q2
2010-03-26 - Kvartalsrapport 2010-Q1
2010-01-13 - Kvartalsrapport 2009-Q1
2009-10-22 - Kvartalsrapport 2009-Q3
2009-06-17 - Kvartalsrapport 2009-Q2
2009-01-28 - Årsstämma
2006-03-01 - Split COALA 1:2
2005-05-04 - Split COALA 1:2

Beskrivning

LandSverige
SektorHälsovård
IndustriMedicinteknik
Coala Life är verksamt inom medicinteknik inriktade mot smartphone- och molnbaserad hjärt- och lungdiagnostik. Bolaget har utvecklat och lanserat Coala Heart Monitor, en produktplattform som möjliggör långtidsmonitorering, analys och algoritmbaserad diagnostik av hjärta och lungor på distans. Bolaget är verksamt inom Europa och USA med huvudkontor i Uppsala.
2022-08-17 07:00:00

Second quarter 2022

  • Net sales increased to SEK 1.6 M (0.9).
  • EBITDA totaled SEK -40.7 M (-9.0).
  • Operating income totaled SEK -41.4 M (-9.8).
  • Profit after tax was SEK -38.5 M (-9.8).
  • Earnings per share was SEK -0.6 (-4.8).
  • Cash flow from operating activities was SEK -50.9 M (-10.2).

The period, January 1, 2022 – June 30, 2022

  • Net sales increased to SEK 2.4 M (2.2).
  • EBITDA totaled SEK -71.6 M (-22.0).
  • Operating income totaled SEK -73.4 M (-23.6).
  • Profit after tax was SEK -70.1 M (-23.7).
  • Earnings per share was SEK -1.3 (-11.8).
  • Cash flow from operating activities was SEK -86.4 M (-24.5).

Events in the quarter

  • On April 13, the company announced a resolution of a fully guaranteed rights issue of approximately SEK 150 M before transaction costs.
  • On April 15, the company announced that it received FDA 510k clearance for remote lung auscultation and enhanced ECG algorithm.
  • In April, the company reported that the Coala Heart Monitor had been recommended by the Medical Technology Product Council for introduction into clinical use in Sweden.
  • On May 30, the Annual General Meeting of Coala-Life Group AB was held, and Christian Jørgensen was elected as a board member.
  • On June 9, the company announced its intention to acquire Vitrics Management, a USA company engaged in patient monitoring.

Events after the end of the quarter

  • On July 4, the company launched a new website.
  • On July 29, the company announced that the estimated completion date of the acquisition of Vitrics Management was moved back to August 14.
  • On August 15, the company announced that the acquisition of Vitrics Management was completed for a purchase price of USD 3.5 M.

Extract from comments from the CEO, Dan Pitulia

During the spring and summer we have continued to work towards a profitable business in the US market. Our venture into Managed RPM, under the name Qorum Partners, has strengthened its position and business is picking up momentum, largely due to an investment in clinical staff. Coala Heart Monitor received an additional FDA 510k clearance in the US, for remote lung auscultation and new ECG analysis algorithm, and, in Sweden, the Medical Technology Product Council (MTP Council) recommended the use of Coala Heart Monitor in Swedish healthcare for patients with symptoms of atrial fibrillation. Shortly before the release of this report, we were also able to complete the acquisition of Vitrics in the US.